Budget Impact of an Individualized Approach in the Treatment of HBeAg-Negative CHB Patients Exploiting the Week-12 Peginterferon Alfa-2a Stopping Rule in Italy
Abstract
Authors
S. Iannazzo M. De Francesco B. Coco M. Brunetto R. Tomic D. Paolini G. Palmieri F. Bonino